VISIT: Global malaria partners tour malaria control projects
On the final day of the three-day 2024 Grand Cha…
MEETING: Global gathering for malaria control, elimination
From Sept 11-13 2024, Ifakara Health Institute and the Gates Foundation, ho…
CONFIRMED: Tanzania’s first-line malaria drug remains effective
A recent study conducted in Tanzania in 2022 has confirmed that the malaria drug known as artemether-lumefantrine (AL), the country’s first-l…
FORUM: Ifakara joins WHO and govt at Global Evidence Summit in Europe
Tanzania was represented at the 2024 Global Evid…
FORUM: Ifakara discusses malaria burden, vaccines at global festival
The Ifakara Health Institute’s Director of…
PARTNERSHIP: Ifakara, Ardhi University discuss MoU implementation
The Ifakara Health Institute Chief Executive, Dr. Honorati Masanja, engaged…
FEATURE: Ifakara scientist on Global Times
In an article published by Global Times on Se…
UNDERWAY: New trial to address mental health challenges among teens with HIV
A new clinical trial is underway in Tanzania, seeking to address the mental health challenges faced by young people living with HIV (YPLWH). The tr…
BLOG: Strengthening Tanzania's early childhood development policies
Farida Katunzi, a Research Scientist at Ifakara Health Institute, highlight…
REVIEW: Potential of “selective indoor spraying” in malaria control
Indoor Residual Spraying (IRS) has long been a key method for controlling malaria control. The method involves spraying all accessible surfaces in …